Pilot Study on the Therapeutic Effects of a Food-Derived Formulation in Patients with Burning Mouth Syndrome

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011212

Enrollment

Registered

2025-11-25

Start date

2024-11-04

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Group A: Conventional treatment group (using general artificial saliva (applied 5 times daily, 3 times per session)): 1 week of explanation and compliance with precautions (artifi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 20 years of age or older - Patients diagnosed with burning mouth syndrome based on medical history, clinical examination, and blood tests

Exclusion criteria

Exclusion criteria: Pregnant or lactating women - Excludes those in vulnerable environments - Excludes those with abnormal blood test results, systemic diseases (e.g., diabetes, thyroid disease), or those taking psychotropic medications

Design outcomes

Primary

Measure	Time frame
Pain index	—

Secondary

Measure	Time frame
Burning sensation index	—

Countries

Korea, Republic of

Contacts

Public ContactSoo-min Ok

Pusan National University Dental Hospital

oksoomin@pusan.ac.kr+82-55-360-5243

Outcome results